Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed Feb 6, 2026 · 10-Q · 37 days after period end · 0001520138-26-000052
| Metric | Q2 2026 | Q2 2025 | Q2 2024 | Q2 2023 |
|---|---|---|---|---|
| Net Income | -$6.07M | -$7.11M | -$8.40M | -$15.69M |
| EPS Diluted | -$0.77 | -$4.55 | -$0.22 | -$0.50 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Feb 6, 2026 · 37 d after period end
